当前位置： SCI文献检索 > JOURNAL OF CARDIOVASCULAR PHARMACOLOGY期刊下所有文献 > Regulatory effect of Rac1 on vascular reactivity after hemorrhagic shock in rats.

Regulatory effect of Rac1 on vascular reactivity after hemorrhagic shock in rats.

Abstract：

:We used isolated superior mesenteric arteries (SMAs) from hemorrhagic-shock rats and hypoxia-treated vascular smooth muscle cells (VSMCs; mimicking the shock state) to observe the effects of platelet-derived growth factor (PDGF; Rac1 stimulator) and NSC23766 (Rac1 antagonist) on vascular reactivity and the relationship with the Rho kinase-myosin light-chain phosphatase (MLCP) and p21-activated kinase (PAK)-myosin light-chain kinase (MLCK) signal pathway. The results indicated that the contractile responses of the SMAs and VSMCs were significantly increased at early shock or after transient hypoxia. NSC23766 (Rac1 antagonist) further increased, whereas PDGF (Rac1 stimulator) decreased the contractile responses of SMAs and VSMCs. In the late period of shock or prolonged hypoxia, the contractile responses of SMAs and VSMCs were significantly decreased; NSC23766 increased (whereas PDGF further decreased) the contractile response of the SMAs and VSMCs. Activation of Rac1 with PDGF significantly increased the activity of PAK and MLCP, and decreased Rho kinase and MLCK activity and 20-kDa myosin light-chain phosphorylation in VSMCs. The PAK inhibitor PAK-18 significantly antagonized the PDGF-induced decrease in MLCK activity, whereas the Rho kinase antagonist Y-27632 further enforced the PDGF-induced increase in MLCP activity. Simple fluid resuscitation did not improve but in combination with NSC23766 significantly improved vascular reactivity and animal survival at 24 hours. This suggested that Rac1 has an inhibitory effect on vasoreactivity after shock. Rac1-mediated regulation of vascular reactivity is mainly through activation of PAK, inhibition of MLCK and inhibition of Rho kinase, unpack the inhibition of Rho kinase to MLCP. Rac1 may be a potential target to treat vascular hyporeactivity in many critical conditions.

journal_name

J Cardiovasc Pharmacol

journal_title

Journal of cardiovascular pharmacology

authors

Li T,Yang G,Xu J,Zhu Y,Liu L

doi

10.1097/FJC.0b013e318215e21d

subject

Has Abstract

pub_date

2011-06-01 00:00:00

pages

656-65

issue

6

eissn

0160-2446

issn

1533-4023

journal_volume

57

pub_type

杂志文章

相关文献

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY文献大全
  • Interaction between the renin-angiotensin-aldosterone and sympathetic nervous systems.

    abstract：:The renin-angiotensin-aldosterone system is mainly involved in the regulation of arterial blood pressure and fluid balance. One of the main stimuli for the secretion of renin present in the renal juxtamedullary cells, but also in some other tissues, is provided by the sympathetic nervous system via the action of norep...

    journal_title：Journal of cardiovascular pharmacology

    pub_type： 杂志文章,评审

    doi：10.1097/00005344-199219006-00013

    authors： Saxena PR

    更新日期：1992-01-01 00:00:00

  • Rosuvastatin reduces plasma lipids by inhibiting VLDL production and enhancing hepatobiliary lipid excretion in ApoE*3-leiden mice.

    abstract：:The present study was designed to investigate the lipid-lowering properties and mechanisms of action of a new HMG-CoA reductase inhibitor, rosuvastatin, in female ApoE*3-Leiden transgenic mice. Mice received a high fat/cholesterol (HFC) diet containing either rosuvastatin (0 [control], 0.00125%, 0.0025%, or 0.005% [w/...

    journal_title：Journal of cardiovascular pharmacology

    pub_type： 杂志文章

    doi：10.1097/00005344-200501000-00010

    authors： Delsing DJ,Post SM,Groenendijk M,Solaas K,van der Boom H,van Duyvenvoorde W,de Wit EC,Bloks VW,Kuipers F,Havekes LM,Princen HM

    更新日期：2005-01-01 00:00:00

  • Antithrombotic potential of GW813893: a novel, orally active, active-site directed factor Xa inhibitor.

    abstract：BACKGROUND:Factor Xa (FXa) has been a target of considerable interest for drug development efforts aimed at suppressing thrombosis. In this report, a new orally active, small molecule, active-site directed FXa inhibitor, GW813893, has been profiled in a succession of in vitro and in vivo assays involved in its preclini...

    journal_title：Journal of cardiovascular pharmacology

    pub_type： 杂志文章

    doi：10.1097/FJC.0b013e31817e9b9e

    authors： Abboud MA,Needle SJ,Burns-Kurtis CL,Valocik RE,Koster PF,Amour AJ,Chan C,Brown D,Chaudry L,Zhou P,Patikis A,Patel C,Pateman AJ,Young RJ,Watson NS,Toomey JR

    更新日期：2008-07-01 00:00:00

  • Effects of single doses of the converting enzyme inhibitor cilazapril in normal volunteers.

    abstract：:The new converting enzyme inhibitor cilazapril, or RO 31-2848, was evaluated in 14 healthy male volunteers. In a pilot study in two subjects, the inhibiting capacity of single oral doses of 5 and 10 mg on the pressure and heart rate response to exogenous angiotensin I was assessed. Both doses reduced the blood pressur...

    journal_title：Journal of cardiovascular pharmacology

    pub_type： 杂志文章

    doi：

    authors： Fasanella d'Amore T,Bussien JP,Nussberger J,Waeber B,Turini GA,Brunner HR,Kler L,Francis RJ

    更新日期：1987-01-01 00:00:00

  • New dihydropyridine calcium channel antagonist, pranidipine, attenuates hypertensive renal injury in Dahl salt-sensitive rats.

    abstract：:Interest in the cardiovascular protective effects of calcium channel antagonists has increased in the past decade. We investigated prevention of vascular wall remodeling by the long-acting calcium channel antagonist pranidipine in 12-week-old Dahl salt-sensitive (SS) rats with high-salt-induced (4% NaCl) hypertension....

    journal_title：Journal of cardiovascular pharmacology

    pub_type： 杂志文章

    doi：10.1097/00005344-199406000-00016

    authors： Uehara Y,Kawabata Y,Ohshima N,Hirawa N,Takada S,Numabe A,Nagata T,Goto A,Yagi S,Omata M

    更新日期：1994-06-01 00:00:00

  • Alpha-adrenoceptor influence on plasma levels of neuropeptide Y-like immunoreactivity and catecholamines during rest and sympathoadrenal activation in humans.

    abstract：:Antecubital venous plasma neuropeptide Y-like immunoreactivity (NPY-LI) and catecholamines were analyzed in six healthy volunteers performing a graded bicycle exercise without medication and after acute administration of clonidine, phentolamine, and nifedipine. During the control exercise, plasma noradrenaline (NA), a...

    journal_title：Journal of cardiovascular pharmacology

    pub_type： 杂志文章

    doi：10.1097/00005344-198811000-00014

    authors： Pernow J,Lundberg JM,Kaijser L

    更新日期：1988-01-01 00:00:00

  • Altered beta-adrenergic sensitivity and protein binding to 1-propranolol in the elderly.

    abstract：:The elderly are reported to be less sensitive to the beta-blocking effects of propranolol. However, age-related changes in the stereoselective pharmacokinetics or protein binding of propranolol enantiomers could have confounded the results of previous studies because only 1-propranolol contributes significantly to the...

    journal_title：Journal of cardiovascular pharmacology

    pub_type： 杂志文章

    doi：10.1097/00005344-199011000-00003

    authors： Tenero DM,Bottorff MB,Burlew BS,Williams JB,Lalonde RL

    更新日期：1990-11-01 00:00:00

  • Adenosine A1 receptors link to smooth muscle contraction via CYP4a, protein kinase C-α, and ERK1/2.

    abstract：:Adenosine A1 receptor (A1AR) activation contracts smooth muscle, although signaling mechanisms are not thoroughly understood. Activation of A1AR leads to metabolism of arachidonic acid, including the production of 20-hydroxyeicosatetraenoic acid (20-HETE) by cytochrome P4504a (CYP4a). The 20-HETE can activate protein ...

    journal_title：Journal of cardiovascular pharmacology

    pub_type： 杂志文章

    doi：10.1097/FJC.0b013e3182919591

    authors： Kunduri SS,Mustafa SJ,Ponnoth DS,Dick GM,Nayeem MA

    更新日期：2013-07-01 00:00:00

  • The properties of cardiac contractile proteins are modulated by autonomic innervation.

    abstract：:The force generators in myocardial cells of rats and rabbits can exist in three different states: relaxed and calcium unresponsive; relaxed and calcium responsive; and contracted. The transition between the two calcium responsive states is produced by the abrupt rise in the concentration of calcium ions during activat...

    journal_title：Journal of cardiovascular pharmacology

    pub_type： 杂志文章

    doi：

    authors： Winegrad S,McClellan G,Weisberg A,Lin LE,Weindling S

    更新日期：1986-01-01 00:00:00

  • Comparison between the effects of MDL 72567 and nifedipine on various cardiovascular parameters in conscious sinoaortic-denervated rats and sham-operated controls.

    abstract：:In this study the effects of a new calcium entry blocking agent, 2,6-dimethyl-3-methoxycarbonyl-4-(2-nitrophenyl)-5-(2-furoyl)-1, 4-dihydropyridine (MDL 72567), were compared with those of nifedipine on blood pressure, heart rate, ECG, and cardiac contractility indices in conscious sinoaortic baroreceptor-denervated (...

    journal_title：Journal of cardiovascular pharmacology

    pub_type： 杂志文章

    doi：10.1097/00005344-198710000-00012

    authors： Petty MA,Spedding M,Di Francesco GF

    更新日期：1987-10-01 00:00:00

  • C-phycocyanin ameliorates doxorubicin-induced oxidative stress and apoptosis in adult rat cardiomyocytes.

    abstract：:Doxorubicin (DOX), a potent antineoplastic agent, poses limitations for its therapeutic use due to the associated risk of developing cardiomyopathy and congestive heart failure. The cardiotoxicity of doxorubicin is associated with oxidative stress and apoptosis. We have recently shown that Spirulina, a blue-green alga...

    journal_title：Journal of cardiovascular pharmacology

    pub_type： 杂志文章

    doi：10.1097/01.fjc.0000191520.48404.27

    authors： Khan M,Varadharaj S,Shobha JC,Naidu MU,Parinandi NL,Kutala VK,Kuppusamy P

    更新日期：2006-01-01 00:00:00

  • Thapsigargin inhibits the response to acetylcholine and substance P but does not interfere with the responses to endothelium-independent agents.

    abstract：:We investigated the influence of the Ca(2+)-ATPase inhibitor thapsigargin (TG) on the vasorelaxant response to different endothelium-dependent and endothelium-independent relaxing agents in an isolated thoracic aorta preparation of the rabbit, precontracted by norepinephrine (NE). Pretreatment with 100 microM L-argini...

    journal_title：Journal of cardiovascular pharmacology

    pub_type： 杂志文章

    doi：10.1097/00005344-199607000-00013

    authors： Amerini S,Filippi S,Parenti A,Ziche M,Ledda F

    更新日期：1996-07-01 00:00:00

  • Phase 1B, Randomized, Double-Blinded, Dose Escalation, Single-Center, Repeat Dose Safety and Pharmacodynamics Study of the Oral NLRP3 Inhibitor Dapansutrile in Subjects With NYHA II-III Systolic Heart Failure.

    abstract：ABSTRACT:The NLRP3 inflammasome has been implicated in the development and progression of heart failure. The aim of this study was to determine the safety of an oral inhibitor of the NLRP3 inflammasome, dapansutrile (OLT1177), in patients with heart failure and reduced ejection fraction (HFrEF). This was a phase 1B, ra...

    journal_title：Journal of cardiovascular pharmacology

    pub_type： 杂志文章

    doi：10.1097/FJC.0000000000000931

    authors： Wohlford GF,Van Tassell BW,Billingsley HE,Kadariya D,Canada JM,Carbone S,Mihalick VL,Bonaventura A,Vecchié A,Chiabrando JG,Bressi E,Thomas G,Ho AC,Marawan AA,Dell M,Trankle CR,Turlington J,Markley R,Abbate A

    更新日期：2020-10-24 00:00:00

  • Influence of angiotensin-converting enzyme inhibition by fosinopril on myocardial perfusion in streptozotocin-diabetic rats.

    abstract：:We examined the influence of the new angiotensin-converting enzyme inhibitor (ACEI) fosinopril on function and perfusion of the diabetic rat heart. Streptozotocin-diabetic rats (60 mg/kg body weight) were treated with fosinopril (10 mg/kg body weight/day) for 4 months. Cardiac performance was analyzed in the isolated ...

    journal_title：Journal of cardiovascular pharmacology

    pub_type： 杂志文章

    doi：10.1097/00005344-199601000-00011

    authors： Rösen P,Rump AF,Rösen R

    更新日期：1996-01-01 00:00:00

  • Interaction between NO donors and iloprost in human vascular smooth muscle, platelets, and leukocytes.

    abstract：:Endothelium-derived relaxing factor (EDRF) and donors of nitric oxide (NO) (glyceryl trinitrate, SIN-1--a metabolite of molsidomine--S-nitroso-N-acetyl-penicillamine, and sodium nitroprusside) but not prostacyclin and its analog, iloprost, relax strips of rabbit aorta. Strips of human coronary artery also relax when e...

    journal_title：Journal of cardiovascular pharmacology

    pub_type： 杂志文章

    doi：

    authors： Gryglewski RJ,Korbut R,Trabka-Janik E,Zembowicz A,Trybulec M

    更新日期：1989-01-01 00:00:00

  • Aspirin Use in Secondary Cardiovascular Protection and the Development of Aspirin-Associated Erosions and Ulcers.

    abstract：:Aspirin for secondary cardiovascular disease prevention is well established, but treatment discontinuation, often because of gastrointestinal mucosal injury or symptoms, can lead to increased risk for cardiovascular events. Proton pump inhibitor therapy is recommended for aspirin-treated patients at gastrointestinal r...

    journal_title：Journal of cardiovascular pharmacology

    pub_type： 杂志文章,随机对照试验

    doi：10.1097/FJC.0000000000000387

    authors： Goldstein JL,Scheiman JM,Fort JG,Whellan DJ

    更新日期：2016-08-01 00:00:00

  • A comparison of plasma, white blood cell, red blood cell, and tissue distribution of amiodarone and desethylamiodarone in anesthetized dogs.

    abstract：:Desethylamiodarone (DA) is a major metabolite of amiodarone (AM), a Class III antiarrhythmic drug. The plasma pharmacokinetics and tissue distribution of AM and DA (10 mg/kg i.v.) were compared in anesthetized dogs. Plasma, white blood cell (WBC), red blood cell (RBC), liver, and skeletal muscle samples were obtained ...

    journal_title：Journal of cardiovascular pharmacology

    pub_type： 杂志文章

    doi：10.1097/00005344-198710000-00002

    authors： Bandyopadhyay S,Somani P

    更新日期：1987-10-01 00:00:00

  • Protection of the ischemic myocardium by the converting-enzyme inhibitor zofenopril: insight into its mechanism of action.

    abstract：:We assessed whether local inhibition of myocardial converting enzyme by captopril and zofenopril reduces the functional and metabolic damage caused by ischemia and reperfusion. First we investigated the effects of zofenopril and captopril on the mechanical function, cellular redox state, and norepinephrine (NE) conten...

    journal_title：Journal of cardiovascular pharmacology

    pub_type： 杂志文章

    doi：

    authors： Ferrari R,Cargnoni A,Curello S,Ceconi C,Boraso A,Visioli O

    更新日期：1992-01-01 00:00:00

  • Effects of inducible nitric oxide synthase inhibition on the rat tail vascular bed reactivity three days after myocardium infarction.

    abstract：:The acute phase of myocardial infarction promotes an inflammatory response that stimulates inducible nitric oxide synthase (iNOS). We investigated the iNOS role on the rat tail vascular bed reactivity 3 days after myocardial infarction. Vasodilator and vasoconstrictor responses were determined in isolated caudal vascu...

    journal_title：Journal of cardiovascular pharmacology

    pub_type： 杂志文章

    doi：10.1097/01.fjc.0000156822.58081.be

    authors： Sartório CL,Pinto VD,Cutini GJ,Vassallo DV,Stefanon I

    更新日期：2005-04-01 00:00:00

  • The inhibition of long-chain fatty acyl-CoA synthetase by enoximone in rat heart mitochondria.

    abstract：:The mechanism by which enoximone, a reported phosphodiesterase inhibitor, inhibits the oxidation of long-chain fatty acids was studied in isolated rat heart mitochondria using a series of 14C-labeled substrates. Enoximone decreased palmitate oxidation in a time- and concentration-dependent manner. Fifty percent inhibi...

    journal_title：Journal of cardiovascular pharmacology

    pub_type： 杂志文章

    doi：10.1097/00005344-199206000-00009

    authors： Abdel-aleem S,Youssef J,Badr M,Morgan P,Frangakis C

    更新日期：1992-06-01 00:00:00

  • Diosgenin Mitigates Streptozotocin Diabetes-induced Vascular Dysfunction of the Rat Aorta: The Involved Mechanisms.

    abstract：:Chronic diabetes mellitus finally leads to serious vascular dysfunction. Diosgenin is a natural steroidal saponin with potential cardiovascular protective effect. In this study, the protective effect of diosgenin was checked on the aorta from streptozotocin-induced diabetic rats. Diabetic rats received diosgenin (40 m...

    journal_title：Journal of cardiovascular pharmacology

    pub_type： 杂志文章

    doi：10.1097/FJC.0000000000000308

    authors： Roghani-Dehkordi F,Roghani M,Baluchnejadmojarad T

    更新日期：2015-12-01 00:00:00

  • Verapamil potentiates vagally mediated atrioventricular chronotropic responses in dogs.

    abstract：:When the cervical vagus nerve is briefly stimulated, a triphasic cardiac chronotropic response ensues: the cardiac cycle length initially increases, then briefly decreases, and subsequently increases again. Verapamil, a calcium channel blocker, alters these responses to acetylcholine when the heart is in sinoatrial no...

    journal_title：Journal of cardiovascular pharmacology

    pub_type： 杂志文章

    doi：10.1097/00005344-198807000-00017

    authors： Wallick DW,Stuesse SL,Crafford W

    更新日期：1988-07-01 00:00:00

  • Probucol reduces myocardial dysfunction during reperfusion after short-term ischemia in rabbit heart.

    abstract：:The effects of probucol, a lipophilic antioxidant, on the myocardial dysfunction (stunning) observed during reperfusion after 15-min ischemia in rabbit heart were studied. Rabbits received food with or without 1% probucol for 3 weeks. They were then anesthetized and prepared for recording of myocardial segment shorten...

    journal_title：Journal of cardiovascular pharmacology

    pub_type： 杂志文章

    doi：10.1097/00005344-199101000-00023

    authors： Dage RC,Anderson BA,Mao SJ,Koerner JE

    更新日期：1991-01-01 00:00:00

  • Desmodium gangeticum (Linn.) DC. exhibits antihypertrophic effect in isoproterenol-induced cardiomyoblasts via amelioration of oxidative stress and mitochondrial alterations.

    abstract：:Cardiac hypertrophy occurs in response to increased workload, such as hypertension or valvular heart disease. Oxidative stress has been implicated in cardiac hypertrophy and in its transition to heart failure. This study was taken up with the objective to evaluate the role of oxidative stress in cardiomyoblast hypertr...

    journal_title：Journal of cardiovascular pharmacology

    pub_type： 杂志文章

    doi：10.1097/FJC.0b013e3182756ad3

    authors： Sankar V,Pangayarselvi B,Prathapan A,Raghu KG

    更新日期：2013-01-01 00:00:00

  • Relaxation of large coronary artery by verapamil, D600, and nifedipine is constrictor selective: comparison with glyceryl trinitrate.

    abstract：:We compared the vasodilator potencies of a number of Ca2+-entry blockers with glyceryl trinitrate (GTN) in isolated ring segments of dog coronary arteries contracted by a variety of substances. Rings were contracted to 80% of maximum by serotonin, phenylephrine (PE), noradrenaline (NA), K+ (KCl), or U46619 (stable thr...

    journal_title：Journal of cardiovascular pharmacology

    pub_type： 杂志文章

    doi：10.1097/00005344-198303000-00026

    authors： Angus JA,Brazenor RM

    更新日期：1983-03-01 00:00:00

  • Effect of nifedipine on cyclic GMP turnover in cultured coronary smooth muscle cells.

    abstract：:We investigated the effects of nifedipine on cyclic GMP turnover and the pertinent enzyme activities in cultured coronary smooth muscle cells (SMC). Nifedipine at high concentrations slightly decreased basal soluble guanylate cyclase activity and inhibited the action of sodium nitroprusside (SNP) but had no effect on ...

    journal_title：Journal of cardiovascular pharmacology

    pub_type： 杂志文章

    doi：10.1097/00005344-199510000-00013

    authors： Kishi Y,Watanabe T,Makita T,Sakita S,Watanabe R,Ashikaga T,Numano F

    更新日期：1995-10-01 00:00:00

  • Drug block of I(kr): model systems and relevance to human arrhythmias.

    abstract：:The long QT-related arrhythmia torsades de pointes (TdP) can arise with mutations in HERG and during treatment with drugs that block cardiac I Kr, the current encoded by HERG. Multiple test systems have been used to assess drug block of I Kr. This study evaluated the I Kr blocking potency of a series of antiarrhythmic...

    journal_title：Journal of cardiovascular pharmacology

    pub_type： 杂志文章

    doi：10.1097/00005344-200111000-00010

    authors： Yang T,Snyders D,Roden DM

    更新日期：2001-11-01 00:00:00

  • Effects of doxazosin and other antihypertensives on serum lipid levels and lipoprotein lipase in the C57BR/cdJ mouse.

    abstract：:Doxazosin has been shown to lower serum cholesterol levels in the cholesterol-fed (0.75% in a synthetic diet that contains sucrose and cholic acid) C57BR/cdJ mouse. These studies show that the drug's main effect is to lower low-density lipoprotein (LDL) cholesterol and leave high-density lipoprotein (HDL) cholesterol ...

    journal_title：Journal of cardiovascular pharmacology

    pub_type： 杂志文章

    doi：10.1097/00005344-198900132-00004

    authors： Krupp MN,Hoover KW,Valentine JJ

    更新日期：1989-01-01 00:00:00

  • Demonstration of proarrhythmic activity with the class IC antiarrhythmic agent encainide in a canine model of previous myocardial infarction.

    abstract：:The antiarrhythmic efficacy and proarrhythmic potential of the class IC antiarrhythmic agent encainide were assessed in subacute and chronic postinfarction canine models, respectively. In conscious dogs with spontaneous premature ventricular complexes (PVCs) at 48 h after anterior myocardial infarction (MI), cumulativ...

    journal_title：Journal of cardiovascular pharmacology

    pub_type： 杂志文章

    doi：10.1097/00005344-199303000-00008

    authors： Wallace AA,Stupienski RF 3rd,Kothstein T,Gehret JR,Lynch JJ Jr

    更新日期：1993-03-01 00:00:00

  • Effects of adenosine and verapamil on anatomic no-reflow in a rabbit model of coronary artery occlusion and reperfusion.

    abstract：:Adenosine and verapamil have successfully been used in the treatment of clinical no-reflow after direct angioplasty for acute myocardial infarction. However, their effects on anatomic perfusion defects in experimental myocardial ischemia/reperfusion are unknown. Thus the area of no-reflow (ANR), visualized after in-vi...

    journal_title：Journal of cardiovascular pharmacology

    pub_type： 杂志文章

    doi：10.1097/00005344-200404000-00014

    authors： Reffelmann T,Kloner RA

    更新日期：2004-04-01 00:00:00